Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Alemtuzumab (Campath® 1-H)

Deborah Davison
Anna D. Schaal
CJON 2005, 9(5), 630-632 DOI: 10.1188/05.CJON.630-632

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or